Company Filing History:
3 out of 156 
2 out of 96 
2 out of 1,744 
Years Active: 1999-2002
Title: The Innovations of Bertrand Huard
Introduction
Bertrand Huard, an inventive mind from L'Haye les Roses, France, has made significant contributions to the field of biomedicine. With a portfolio boasting three patents, he has focused on advancing therapeutic options through novel protein and polypeptide innovations.
Latest Patents
Among his most recent patents is the invention concerning mutants of the LAG-3 proteins and the nucleotides encoding these mutants. This invention details a purified polypeptide that corresponds to a mutated form of the soluble LAG-3 protein or one of its fragments, particularly highlighting the extracellular domains D1 and D2. Additionally, he holds a patent for a therapeutic composition containing antibodies to a soluble polypeptide fraction which consists of all or part of multiple immunoglobulin-type extracellular LAG-3 protein domains. This fraction demonstrates a specificity equal to that of LAG-3 concerning its ligand, showcasing his innovative approach in therapeutic development.
Career Highlights
Throughout his career, Huard has been associated with pivotal institutions that have enriched his research experience. Notably, he worked with Applied Research Systems Ars Holding N.V. and the Institut Gustave Roussy, both of which are renowned for their focus on cutting-edge biomedical research.
Collaborations
Bertrand Huard has collaborated with prominent professionals in the field, including Frederic Triebel and Florence Faure. These partnerships have undoubtedly facilitated the exchange of ideas and fostered advancements in his research endeavors.
Conclusion
In summary, Bertrand Huard's work exemplifies innovation in the biomedicine sector, particularly through his patents related to LAG-3 proteins and their therapeutic applications. His continuous efforts to improve medical treatments highlight the vital role inventors play in advancing science and technology.